Data demonstrates that NKT cells are activated in airways in IPF patients and inhibition of type 1 invariant NKT (iNKT) cell activity can ameliorate bleomycin-induced pulmonary fibrosis in mice...
Company is strategically building a global patent estate in key territories for a growing pipeline targeting potentially high-value indications in need of innovation...
GRI Bio (NASDAQ: GRI ) stock is falling on Wednesday after the clinical-stage biopharmaceutical company announced a proposed public offering for its shares. GRI Bio plans to offer up to 2,238,806 sha...
GRI's common stock is expected to begin trading on a post-split adjusted basis on June 18, 2024 LA JOLLA, CA, June 14, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or th...
Data recently presented at the 2024 American Thoracic Society International Conference and the 14 th International Congress on Autoimmunity...
Data presented at the 14 th International Congress on Autoimmunity Encouraging preclinical data observed to date on par with OFEV ® (nintedanib), a leading tyrosine kinase inhibitor with 2025 project...
NORTHAMPTON, MA / ACCESSWIRE / May 20, 2024 / GoDaddyOriginally published in GoDaddy's 2023 Sustainability ReportCorporate GovernanceWe're committed to generating value and earning trust.Delivering on...
Compared to controls, mice treated with GRI-0621 showed improved fibrosis and immunopathology; Inhibition of type 1 invariant Natural Killer T (iNKT) cell activity led to a decrease in fibrosis score ...
Maintaining commitment to the target of reducing Scope 1 and 2 carbon emissions by an average of 5% every year until 2030 BEIJING and TEL AVIV, Israel, May 20, 2024 /PRNewswire/ -- ADAMA Ltd. (SZSE 00...